Literature DB >> 24917658

Staggered and tapered antibiotic withdrawal with administration of kefir for recurrent Clostridium difficile infection.

Johan S Bakken1.   

Abstract

Daily administration of the probiotic kefir given in combination with a staggered and tapered antibiotic withdrawal regimen may resolve recurrent Clostridium difficile infection as effectively as fecal microbiota transplantation.
© The Author 2014. Published by Oxford University Press on behalf of the Infectious Diseases Society of America. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Clostridium difficile; antibiotic withdrawal; diarrhea; kefir; recurrent

Mesh：

Substances：

Year:  2014        PMID： 24917658     DOI： 10.1093/cid/ciu429

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


  16 in total

1.  Management of Clostridium difficile Infection.

Authors:  Layth S Al-Jashaami; Herbert L DuPont
Journal:  Gastroenterol Hepatol (N Y)       Date:  2016-10

Review 2.  Extended duration vancomycin in recurrent Clostridium difficile infection: a systematic review.

Authors:  Madison M Murphy; Edna Patatanian; Mark A Gales
Journal:  Ther Adv Infect Dis       Date:  2018-09-12

Review 3.  Understanding the mechanisms of faecal microbiota transplantation.

Authors:  Alexander Khoruts; Michael J Sadowsky
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2016-06-22       Impact factor: 46.802

Review 4.  Clinical Practice and Infrastructure Review of Fecal Microbiota Transplantation for Clostridium difficile Infection.

Authors:  Brendan J Kelly; Pablo Tebas
Journal:  Chest       Date:  2017-09-18       Impact factor: 9.410

5.  Probiotics for Prevention of Clostridium difficile Infection in Hospitalized Patients: Is the Jury Still Out?

Authors:  Krishna Rao; Vincent B Young
Journal:  Gastroenterology       Date:  2017-04-28       Impact factor: 22.682

Review 6.  Control of Clostridium difficile Infection by Defined Microbial Communities.

Authors:  James Collins; Jennifer M Auchtung
Journal:  Microbiol Spectr       Date:  2017-09

Review 7.  Epidemiology, Diagnosis, and Management of Clostridium difficile Infection in Patients with Inflammatory Bowel Disease.

Authors:  Krishna Rao; Peter D R Higgins
Journal:  Inflamm Bowel Dis       Date:  2016-07       Impact factor: 5.325

8.  Administration of probiotic kefir to mice with Clostridium difficile infection exacerbates disease.

Authors:  Jennifer K Spinler; Aaron Brown; Caná L Ross; Prapaporn Boonma; Margaret E Conner; Tor C Savidge
Journal:  Anaerobe       Date:  2016-05-11       Impact factor: 3.331

Review 9.  Probiotics as adjunctive therapy for preventing Clostridium difficile infection - What are we waiting for?

Authors:  Jennifer K Spinler; Caná L Ross; Tor C Savidge
Journal:  Anaerobe       Date:  2016-05-13       Impact factor: 3.331

10.  Next-Generation Probiotics Targeting Clostridium difficile through Precursor-Directed Antimicrobial Biosynthesis.

Authors:  Jennifer K Spinler; Jennifer Auchtung; Aaron Brown; Prapaporn Boonma; Numan Oezguen; Caná L Ross; Ruth Ann Luna; Jessica Runge; James Versalovic; Alex Peniche; Sara M Dann; Robert A Britton; Anthony Haag; Tor C Savidge
Journal:  Infect Immun       Date:  2017-09-20       Impact factor: 3.441
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.